Anuh Pharma AGM Approves Director Reappointments, Remuneration Revision

Date: 14th August, 2026

Reappointment of Directors:

Mr. Bipin Nemchand Shah (DIN: 00083244) reappointed as Non-Executive Non-Independent Director effective 12th August 2026 under Section 152(6) of Companies Act, 2013
Mr. Arun Lalchand Todarwal (DIN: 00020916) reappointed as Non-Executive Non-Independent Director effective 12th August 2026 under Section 152(6) of Companies Act, 2013
Mr. Ankit Kishor Chande, Cost Accountants (Certificate of Practice No. 34051) reappointed as Cost Auditor for financial year ending March 2027

Director Profiles:

Mr. Bipin Shah: Chemical Engineer, Vice Chairman of Anuh Pharma Ltd., 50 years experience in pharmaceutical field, responsible for distribution, C & F and Mother Depot operations of SK Group. President of Thane Belapur Industries Association.
Mr. Arun Todarwal: Fellow member of Institute of Chartered Accountants of India, practicing since 1981. Expertise in Statutory Audits, Internal Audits, Management and Systems Audits, Due diligences, Taxation, International Taxation. Member of Institute of Internal Auditors, National Centre for Quality Management, Bombay Management Association and Bombay Chartered Accountants Society.
Mr. Ankit Chande: Qualified Cost Accountant with 12+ years experience, firm serves 17 different industries including Pharmaceutical, Chemical & Construction Industry.

Relationships:

Mr. Bipin Shah is father of Mr. Ritesh Shah (Joint Managing Director) and Mr. Vivek Shah (Joint Managing Director)
No inter-se relationship among other directors

Compliance Status:

All reappointed directors and auditor are not debarred from holding office by virtue of any SEBI Order or any other authority

Revision in remuneration payable to Mr. Ritesh B. Shah (DIN: 02496729), Joint Managing Director for financial year 2026-27
Revision in remuneration payable to Mr. Vivek Shah (DIN: 02878724), Joint Managing Director for financial year 2026-27
[Note: Specific remuneration figures or percentage changes not disclosed in the document]

Approval of adoption of new set of Memorandum of Association (MOA) as per Companies Act, 2013, subject to shareholder approval
Approval of adoption of new set of Articles of Association (AOA) as per Companies Act, 2013, subject to shareholder approval